Cogent Biosciences (COGT) executive compensation, 2026 proxy

Andrew Robbins, Chief Executive Officer, was paid $27.8M in 2025, up 465% from $4.9M the year before. The CEO-to-median-employee pay ratio was 95:1, on median employee pay of $292,285.

Filed
April 23, 2026
Annual meeting
June 9, 2026
Pay year
2025
Named executives
5
CEO total pay
$27.8M+465% vs prior year
CEO to median employee
95:1median $292,285
CEO pay in equity
95%$26.4M in awards
Prior say-on-pay support
99%of votes cast
CEO Total Compensation
$27.8M2025 total compensation
Annual Bonus Payout
135%Based on corporate performance goals
CEO At-Risk Pay
97%Proportion of total pay
Say-on-Pay Support
99%2025 annual meeting support

How Robbins was paid

$27.8M in total for 2025, as reported in the Summary Compensation Table. Equity awards are valued at grant, not at what they turned out to be worth.

Salary3%Bonus0%Stock awards47%Option awards48%Non-equity incentive2%All other compensation0%

Named executive officers

ExecutiveTotal
Andrew RobbinsChief Executive Officer$27,762,684
John GreenChief Financial Officer$8,546,329
Jessica SachsChief Medical Officer$9,178,177
Cole PinnowChief Commercial Officer$8,839,548
John RobinsonChief Scientific Officer$9,150,297

What changed and why

  • $27.8MChief executive officer total compensation increased to $27,762,684 in 2025 due to new equity awards and performance-based grants.
  • 4%Named executive officers received annual salary increases of 4% in January and 4.5% to 15.8% in December.
  • 135%Annual bonuses for named executive officers paid out at 135% of target based on corporate performance goals.
  • New performance-based restricted stock units were granted in September with a three-year performance period ending in December 2028.
  • 97%Compensation pay mix is highly at risk, representing 97% for the chief executive officer and 94% for other named executive officers.

About this page

Figures are automated and can be wrong; check the filing for the exact numbers. Totals follow SEC rules, which value stock and option awards at grant. Read the DEF 14A proxy statement for footnotes and the compensation committee's full reasoning.